Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

NCT00518115 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

361

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Albiglutide (GSK716155) or exenatide

Sponsor

GlaxoSmithKline